Article Details

Talaris pulls off $150M IPO to tackle organ rejection, autoimmune disorders

Retrieved on: 2021-05-07 14:26:15

Tags for this article:

Click the tags to see associated articles and topics

Talaris pulls off $150M IPO to tackle organ rejection, autoimmune disorders. View article details on hiswai:

Excerpt

One of the immune systems is their own, while the second is made up of immune cells produced when ... Talaris calls this a “chimeric immune system.

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo